Cannabidiol alters psychophysiological, craving and anxiety responses in an alcohol cue reactivity task: A cross‐over randomized controlled trial
In a short-term regimen, CBD appears to modulate PNS activity, reduce cue-elicited anxiety during cue exposure and reduce alcohol craving after cue exposure while not significantly impairing cognition. Large, parallel clinical trials with longer term regimens are now needed to determine the therapeutic potential of CBD in the management of AUD.
Authors
- Kirsten C. Morley (ORCID: https://orcid.org/0000-0002-0868-9928)
- Warren Logge (ORCID: https://orcid.org/0000-0003-0777-3033)
- Anastasia Suraev (ORCID: https://orcid.org/0000-0002-5993-2246)
- Iain S. McGregor (ORCID: https://orcid.org/0000-0002-9307-7159)
- Tristan Hurzeler (ORCID: https://orcid.org/0000-0002-6472-6615)
- Joshua Watt (ORCID: https://orcid.org/0000-0002-6697-2158)
- Paul Haber (ORCID: https://orcid.org/0000-0001-8915-8872)
Institutions
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- Sydney Local Health District (AU)
Publication Details
- Journal
- Alcohol Clinical and Experimental Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/acer.15514
- Citations
- 9
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 12.55
Funders
- Australian Government
- Medical Research Council
- National Health and Medical Research Council